1. Clinical pharmacological innovation in the treatment of depression. Issue 4 (3rd April 2023) Authors: Witkin, Jeffrey M; Golani, Lalit K; Smith, Jodi L Journal: Expert review of clinical pharmacology Issue: Volume 16:Issue 4(2023) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Positive Allosteric Modulator of Alpha-2/3-Containing γ-Aminobutyric Acid Type A Receptors, KRM-II-81, Is Active in Pharmacoresistant Models of Epilepsy and in Human Epileptic Tissue. (1st September 2019) Authors: Smith, Jodi L; Ping, Xingie; Jin, Xiaoming; Golani, Lalit K; Li, Guanguan; Rashid, Farjana; Jahan, Rajwana; Cook, James M; Witkin, Jeffrey M Journal: Neurosurgery Issue: Volume 66(2010)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Positive Allosteric Modulator of Alpha‐2/3‐Containing γ‐Aminobutyric Acid Type A Receptors, KRM‐II‐81, Is Active in Pharmacoresistant Models of Epilepsy and in Human Epileptic Tissue. (September 2019) Authors: Smith, Jodi L; Ping, Xingie; Jin, Xiaoming; Golani, Lalit K; Li, Guanguan; Rashid, Farjana; Jahan, Rajwana; Cook, James M; Witkin, Jeffrey M Journal: Neurosurgery Issue: Volume 66(2019)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗